Progress in Research Integrity: Defining and Managing Conflict of Interest
暫譯: 研究誠信的進展:定義與管理利益衝突

Redman, Barbara K.

  • 出版商: Springer
  • 出版日期: 2026-07-03
  • 售價: $3,240
  • 貴賓價: 9.5$3,078
  • 語言: 英文
  • 頁數: 204
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3032274788
  • ISBN-13: 9783032274786
  • 相關分類: 管理與領導 Management-leadership
  • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This book follows Dr. Redman's 2023 book, Reconstructing Research Integrity by addressing in much greater depth one of the most consequential but ill-defined constructs in research integrity - conflict of interest (COI). COI in biomedical research is ubiquitous but so poorly defined that its frequency and consequences can rarely be identified. Many research sectors and actors have little to no guidance about how to identify and manage their own COI or those of the institutions and sectors in which they work. In addition, while the current political climate casts doubt on the existence/relevance of COI, the starkness of its tactics can provide an opportunity to move COI management beyond even the current level considered acceptable.

Progress in Research Integrity is ideal for research administrators, policy advisors, researchers, and consultants.

商品描述(中文翻譯)

這本書是延續 Dr. Redman 在 2023 年出版的書籍《重建研究誠信》(Reconstructing Research Integrity),更深入地探討了研究誠信中一個最具影響力但定義模糊的概念——利益衝突(conflict of interest, COI)。在生物醫學研究中,利益衝突無處不在,但其定義模糊,以至於其頻率和後果很少能被識別。許多研究領域和參與者對於如何識別和管理自身的利益衝突或其所屬機構和領域的利益衝突幾乎沒有指導。此外,儘管當前的政治氣候對利益衝突的存在性和相關性提出了質疑,但其策略的明顯性卻提供了一個機會,讓利益衝突的管理超越目前被認為可接受的水平。

《研究誠信的進展》(Progress in Research Integrity)非常適合研究管理者、政策顧問、研究人員和顧問。

作者簡介

Barbara K. Redman is Associate, Division of Medical Ethics, NYU Grossman School of Medicine. She has an extensive list of publications in research integrity, research misconduct and research ethics in general. Through a Fogarty training grant to NYU and the University of Ghana, Dr. Redman teaches research integrity to Ghanian Fogarty Fellows who are addressing, through empirical and theoretical work, issues of research integrity in their own country. As a Senior Fellow in the GE2P2 Global Foundation, she leads teams providing consultation on issues of research integrity to large and small global pharmaceutical/biotech companies. Dr. Redman has served the US Office of Research Integrity as a research grant reviewer and as a Special Consultant. She served for several years on the Wayne State University School of Medicine IRB and has been a reviewer for a wide range of bioethics and related journals.

In addition to the PhD, Dr. Redman holds a masters degree in bioethics from the University of Pennsylvania, was a Visiting Scholar at the Kennedy Institute of Ethics, Georgetown University, a Fellow in Medical Ethics at Harvard Medical School, a Senior Fellow at the University of Pennsylvania Center for Bioethics and a Network Fellow at the Edmond J. Safra Center for Ethics at Harvard University. She holds honorary doctorates from Georgetown University and the University of Colorado.

作者簡介(中文翻譯)

巴巴拉·K·雷德曼(Barbara K. Redman)是紐約大學格羅斯曼醫學院(NYU Grossman School of Medicine)醫學倫理學部的副研究員。她在研究誠信、研究不當行為及一般研究倫理方面擁有廣泛的出版紀錄。透過福嘉提(Fogarty)訓練獎學金,雷德曼博士在紐約大學和加納大學教授研究誠信,幫助加納的福嘉提研究員透過實證和理論工作,解決他們國內的研究誠信問題。作為GE2P2全球基金會的高級研究員,她領導團隊為大型和小型全球製藥/生技公司提供有關研究誠信的諮詢。雷德曼博士曾擔任美國研究誠信辦公室的研究補助審查員及特別顧問。她在韋恩州立大學醫學院的機構審查委員會(IRB)服務多年,並擔任多種生物倫理及相關期刊的審稿人。

除了博士學位外,雷德曼博士還擁有賓夕法尼亞大學的生物倫理碩士學位,曾擔任喬治城大學甘迺迪倫理學研究所的訪問學者,哈佛醫學院的醫學倫理研究員,賓夕法尼亞大學生物倫理中心的高級研究員,以及哈佛大學艾德蒙·J·薩夫拉倫理中心的網絡研究員。她獲得了喬治城大學和科羅拉多大學的榮譽博士學位。